2014-2018 Phase I Study Trends and Market Outlook

  • ID: 3300341
  • Report
  • Region: Global
  • 91 Pages
  • Industry Standard Research (ISR)
1 of 5

FEATURED COMPANIES

  • Celerion
  • DaVita Clinical Research
  • ICON
  • inVentiv Health Clinical
  • PAREXEL
  • PRA
  • MORE
Staying up-to-date with industry practices and usage patterns in this critical stage of clinical development is essential to making informed decisions regarding your own Phase I research, regardless of whether you work at a sponsor organization or a service provider.

This report provides an overview of current market dynamics in the Phase I space as well as an outlook of what our survey respondents, all Phase I decision-makers at sponsor organizations, envision the marketplace will look like in 2018.

This research industry also explores the perceptions and selection of Phase I service providers. Understanding these dynamics can help both study sponsors and CROs better evaluate their position in the marketplace and prepare for upcoming changes and new trends.

What you will learn in this report:

- 4-year examination of the industry’s Phase I market dynamics (i.e. study volume, outsourcing spend)
- Average per company spend on Phase I studies and dollar value of outsourced studies
- Criteria sponsors use to select (and disqualify) clinical service providers
- Sponsor predictions and preferences for future changes in Phase I studies
- Detailed examination of service provider selection for simple vs. complex studies

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Celerion
  • DaVita Clinical Research
  • ICON
  • inVentiv Health Clinical
  • PAREXEL
  • PRA
  • MORE
1. Copyright and Usage Guidelines

2. Introduction

3. Methodology
- Respondent Demographics and Qualifications
- Participant Geography
- Participant Company Size

4. Phase I Market Dynamics
- Phase I Study Volume
- Top Forces with Potential to Increase Phase I Study Volume
- Top Forces with Potential to Decrease Phase I Study Volume
- Phase I Outsourcing
- In-House Phase I Unit Ownership
- Outsourcing Spend with Service Provider Type
- Dollar Value of Outsourced Studies

5. Service Provider Perceptions and Selection
- Outsourcing Decision-Making Responsibility
- Top 3 Most Important Service Provider Attributes – Simple vs. Complex Studies
- Reasons for Service Provider Preference
- Critical Attributes for Phase I Service Providers
- Service Provider Preference
- Most Considered Providers – Simple vs. Complex Studies
- Preferred Provider Agreements
- Number of Preferred Providers
- Difficulty Using a Non-Preferred Provider

6. Trends and Predictions
- Geography
- Use of Multiple Countries
- Phase I Studies by Region
- Geography Predictions for Phase I Recruiting
- Complexity
- Change in Study Complexity
- Use of Multiple Sites / Centers

7. Study Data
- Phase I Study Volume and Design
- Phase I Study Volume
- Change in Total Phase I Study Volume
- Forces with Potential to Increase Phase I Study Volume
- Forces with Potential to Decrease Phase I Study Volume
- Phase I Study Subjects
- Development Stage Assets vs. Commercialized Products
- Phase I Studies by Region
- In-House Phase I Units
- Location of In-House Phase I Units
- Number of Beds in In-House Phase I Units
- Adaptive Trial Designs

8. Phase I Outsourcing
- Outsourcing Decision-Making Responsibility
- Phase I Studies – Percent Outsourced
- Change in Outsourced Phase I Study Volume
- Dollar Value of Outsourced Phase I Studies
- Outsourcing Spend with Service Provider Type – Patient Populations
- Outsourcing Spend with Service Provider Type – Healthy Volunteers
- Benefits of Using Large Full-Service CROs
- Benefits of Using Mid-Size Multi-Service CROs
- Benefits of Using Dedicated Phase I Providers
- Benefits of Using Academic Medical Centers
- Phase I Activity Outsourcing
- Forces Affecting Phase I Outsourcing

9. Service Provider Perceptions and Selection
- Attribute Importance for Complex Phase I Studies
- Attribute Importance for Simple Phase I Studies
- Reasons Service Providers Lose Bids
- Number of Preferred Providers – Current
- Number of Preferred Providers – In 2018
- Difficulty Using a Non-Preferred Provider
- Service Provider Familiarity
- Service Provider Use
- Most Considered Providers – Simple vs. Complex Studies
- Service Provider Preference
- Reasons for Service Provider Preference
- Verbatim Responses for Service Provider Preference

10. Algorithme Partners
- Celerion
- Clinical Research Services (CRS)
- Covance
- DaVita Clinical Research
- DCRI-Duke
- ICON
- INC Research
- inVentiv Health Clinical
- Medpace
- PAREXEL
- PPD
- PRA
- Premier Research
- Quintiles
- SGS Life Sciences
- Theorem
- US Oncology
- Worldwide Clinical Trials

11. Phase I Trends and Predictions

12. Recruiting Healthy Volunteers in India

13. Recruiting Patients in India
- Recruiting Healthy Volunteers in China
- Recruiting Patients in China
- Complexity of Phase I Studies
- Clinic / Bed Space Availability
- Change in Volume of Studies in Patient Populations
- Change in Use of Multiple Sites / Centers
- Change in Use of Multiple Countries
- Change in Use of Hospitals or Academic Centers
- Critical Attributes for Phase I Service Providers

14. Respondent Demographics
- Company Type
- Decision Making Responsibility
- Drug Development Responsibilities
- Job Title
- Involvement in Outsourced Activities
- Involvement in Drug Development Process
- Respondent Location
- Drug Development Involvement by Phase
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Celerion
- Clinical Research Services (CRS)
- Covance
- DCRI-Duke
- DaVita Clinical Research
- ICON
- INC Research
- Medpace
- PAREXEL
- PPD
- PRA
- Premier Research
- Quintiles
- SGS Life Sciences
- Theorem
- US Oncology
- Worldwide Clinical Trials
- inVentiv Health Clinical
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll